Are peptides legal in Michigan?

Can a Michigan resident get peptides by telehealth?

Michigan's telehealth provisions are in the Public Health Code, MCL 333.16283 through 333.16288 (2016 Public Act 359, effective March 29, 2017). A health professional must obtain the patient's consent before providing a telehealth service (MCL 333.16284). Under MCL 333.16285, a professional providing a telehealth service may prescribe a drug if the professional is a prescriber acting within scope of practice, and, for controlled substances, meets the controlled substance requirements that apply to that professional; the prescriber must also refer the patient to geographically accessible care when medically necessary. The telehealth professional must hold a Michigan license. The statute does not separately address whether a store-and-forward or questionnaire encounter is sufficient; that turns on the standard of care, so this record leaves asynchronous prescribing unconfirmed. None of the peptides in this database are controlled substances. [1] [2]

How does the Michigan pharmacy board treat compounding?

The Board of Pharmacy, housed in LARA, regulates pharmacy under Part 177 of the Public Health Code (MCL 333.17701 to 333.17780) and the Board of Pharmacy General Rules in the Michigan Administrative Code (Part 3, pharmacy licenses, R 338.531 to R 338.539, and Part 6, practice of pharmacy, R 338.582 to R 338.591). MCL 333.17748 requires a pharmacy, whether or not located in Michigan, to be licensed to do business in the state; MCL 333.17748e sets narrow conditions under which a licensed out-of-state pharmacy may deliver through a Michigan-licensed wholesale distributor-broker. After the 2012 compounding outbreak, Michigan enacted MCL 333.17748a (2014 Public Act 280, effective September 30, 2014), which requires a pharmacy that provides compounding services for sterile pharmaceuticals to hold current accreditation from a Board-approved national accrediting organization, or to show USP compliance in a manner the Board determines, to verify that status with each license renewal, and to notify the department within 30 days of a complaint from another state or a federal investigation about its compounding. Under R 338.533 the Board adopts USP chapters 795 and 797 (both revised 2023) as the compounding standards, and under R 338.534 an out-of-state pharmacy that will provide sterile compounded preparations in Michigan must have an inspection completed no more than 18 months before its initial or renewal application, by the department, a Board-recognized national inspection program, an approved accrediting organization, or its home-state licensing agency. Michigan has no state bulks list; peptide eligibility follows the federal 503A framework. [1] [3] [4] [5] [6] [7] [8]

Can you get compounded GLP-1s in Michigan?

A telehealth GLP-1 program shipping compounded injections into Michigan must use a pharmacy that holds a Michigan pharmacy license under MCL 333.17748, which patients can check in the LARA license verification system. [1] [3] [11]

Prices by channel: semaglutide cost, tirzepatide cost.

Approvals, shortage history, and prices for every GLP-1 we track are on the GLP-1 hub.

What is the legal access path in Michigan?

Find a provider in Michigan

• Compounding pharmacies in Michigan
• Clinics in Michigan
• Telehealth providers in Michigan

Is it legal to buy research peptides in Michigan?

Part 177 of the Public Health Code restricts the dispensing and sale of prescription drugs to licensed pharmacies and prescribers, and a seller of "research use only" injectable peptides to Michigan consumers holds no such license. [3] [12]

Peptide-specific notes for Michigan

No peptide-specific rule identified for this jurisdiction. The general compounding and telehealth rules above apply, and the federal record covers semaglutide, tirzepatide, and BPC-157.

Frequently asked questions

Sources

Numbered citations above point to these primary sources: the state statute or rule, the pharmacy board, and federal FDA guidance.